中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 37 Issue 3
Mar.  2021
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2021  >  37(3): 527-531

Management algorithm for prevention of mother-to-child transmission of hepatitis B virus(2021)

DOI: 10.3969/j.issn.1001-5256.2021.03.007
  • Received Date: 2021-01-30
  • Accepted Date: 2021-01-30
  • Published Date: 2021-03-20
    Abstract
    • FullText(HTML)
  • loading
    • References(28)
  • [1]
    World Health Organization. Global health sector strategy on viral hepatitis 2016-2021[EB/OL]. (2016-06)[2021-02-01]. https://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/.
    [2]
    Chinese Foundation for Hepatitis Prevention and Control; Chinese Society of Infectious Diseases, Chinese Medical Association; Chinese Society of Hepatology, Chinese Medical Association. Management algorithm for interrupting mother-to-child transmission of hepatitis B[J]. J Clin Hepatol, 2017, 33(7): 1214-1217. (in Chinese) DOI: 10.3969/j.issn.1001-5256.2017.07.003

    中国肝炎防治基金会, 中华医学会感染病学分会, 中华医学会肝病学分会. 乙型肝炎母婴阻断临床管理流程[J]. 临床肝胆病杂志, 2017, 33(7): 1214-1217. DOI: 10.3969/j.issn.1001-5256.2017.07.003
    [3]
    HOU J, CUI F, DING Y, et al. Management algorithm for interrupting mother-to-child transmission of hepatitis B virus[J]. Clin Gastroenterol Hepatol, 2019, 17(10): 1929-1936. e1. DOI: 10.1016/j.cgh.2018.10.007
    [4]
    Chinese Society of Infectious Diseases, Chinese Medical Association; Chinese Society of Hepatology, Chinese Medical Association. Guidelines for the prevention and treatment of chronic hepatitis B (version 2019)[J]. J Clin Hepatol, 2019, 35(12): 2648-2669. (in Chinese) DOI: 10.3969/j.issn.1001-5256.2019.12.007

    中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35(12): 2648-2669. DOI: 10.3969/j.issn.1001-5256.2019.12.007
    [5]
    Obstetrics Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association; Chinese Society of Perinatal Medicine, Chinese Medical Association. 2020 clinical guidelines on prevention of mother-to-child transmission of hepatitis B virus[J]. J Clin Hepatol, 2020, 36(7): 1474-1481. (in Chinese) DOI: 10.3760/cma.j.cn112141-20200213-00101

    中华医学会妇产科学分会产科学组, 中华医学会围产医学分会. 乙型肝炎病毒母婴传播预防临床指南(2020)[J]. 临床肝胆病杂志, 2020, 36(7): 1474-1481. DOI: 10.3760/cma.j.cn112141-20200213-00101
    [6]
    World Health Organization. Prevention of mother-to-child transmission of hepatitis B virus: guidelines on antiviral prophylaxis in pregnancy[EB/OL]. (2020-07-27)[2021-02-01].https://www.who.int/publications/i/item/978-92-4-000270-8.
    [7]
    Chinese Society of Hepatology, Chinese Medical Association. Consensus on the management of hepatitis B virus infection in women of childbearing age[J]. J Clin Hepatol, 2018, 34(6): 1176-1180. (in Chinese) DOI: 10.3969/j.issn.1001-5256.2018.06.008

    中华医学会肝病学分会. 感染乙型肝炎病毒的育龄女性临床管理共识[J]. 临床肝胆病杂志, 2018, 34(6): 1176-1180. DOI: 10.3969/j.issn.1001-5256.2018.06.008
    [8]
    Chinese Society of Hepatology, Chinese Medical Association, China Grade Center. 2019 Chinese practice guideline for prevention and treatment of hepatitis B virus mother-to-child transmission[J]. Chin J Infect Dis, 2019, 37(7): 388-396. https://www.cnki.com.cn/Article/CJFDTOTAL-LCGD202001019.htm

    中华医学会感染病学分会, 中国Grade中心. 中国乙型肝炎病毒母婴传播防治指南[J]. 中华传染病学杂志, 2019, 37(7): 388-396. https://www.cnki.com.cn/Article/CJFDTOTAL-LCGD202001019.htm
    [9]
    ZHANG H, PAN CQ, PANG Q, et al. Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice[J]. Hepatology, 2014, 60(2): 468-476. DOI: 10.1002/hep.27034
    [10]
    CHEN HL, LEE CN, CHANG CH, et al. Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus[J]. Hepatology, 2015, 62(2): 375-386. DOI: 10.1002/hep.27837
    [11]
    PAN CQ, DUAN Z, DAI E, et al. Tenofovir to prevent hepatitis B transmission in mothers with high viral load[J]. N Engl J Med, 2016, 374(24): 2324-2334. DOI: 10.1056/NEJMoa1508660
    [12]
    JOURDAIN G, NGO-GIANG-HUONG N, HARRISON L, et al. Tenofovir versus placebo to prevent perinatal transmission of hepatitis B[J]. N Engl J Med, 2018, 378(10): 911-923. DOI: 10.1056/NEJMoa1708131
    [13]
    ZENG QL, YU ZJ, JI F, et al. Tenofovir alafenamide to prevent perinatal hepatitis B transmission: A multicenter, prospective, observational study[J]. Clin Infect Dis, 2021.[Online ahead of print]
    [14]
    DING Y, CAO L, ZHU L, et al. Efficacy and safety of tenofovir alafenamide fumarate for preventing mother-to-child transmission of hepatitis B virus: A national cohort study[J]. Aliment Pharmacol Ther, 2020, 52(8): 1377-1386. DOI: 10.1111/apt.16043
    [15]
    YIN X, HAN G, ZHANG H, et al. A real-world prospective study of mother-to-child transmission of HBV in China using a mobile health application (shield 01)[J]. J Clin Transl Hepatol, 2020, 8(1): 1-8. http://www.researchgate.net/publication/339724575_A_Real-world_Prospective_Study_of_Mother-to-child_Transmission_of_HBV_in_China_Using_a_Mobile_Health_Application_Shield_01
    [16]
    Polaris Observatory Collaborators. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: A modelling study[J]. Lancet Gastroenterol Hepatol, 2018, 3(6): 383-403. http://www.sciencedirect.com/science/article/pii/S2468125318300566
    [17]
    CUI F, WOODRING J, CHAN P, et al. Considerations of antiviral treatment to interrupt mother-to-child transmission of hepatitis B virus in China[J]. Int J Epidemiol, 2018, 47(5): 1529-1537. http://europepmc.org/abstract/MED/29757383
    [18]
    National Health Commission of the People's Republic of China. Working standard for prevention of mother-to-child transmission of AIDS, syphilis, and hepatitis B(2020)[EB/OL]. (2020-11-25)[2021-02-01]http://www.nhc.gov.cn/fys/s3581/202011/fc7b46b2b48b45a69bd390ae3a62d065.shtml. ( in Chinese )

    国家卫生健康委员会妇幼健康司. 预防艾滋病、梅毒和乙肝母婴传播工作规范(2020年版)[EB/OL]. (2020-11-25) [2021-02-01 ]http://www.nhc.gov.cn/fys/s3581/202011/fc7b46b2b48b45a69bd390ae3a62d065.shtml.
    [19]
    PAN CQ, ZOU HB, CHEN Y, et al. Cesarean section reduces perinatal transmission of hepatitis B virus infection from hepatitis B surface antigen-positive women to their infants[J]. Clin Gastroenterol Hepatol, 2013, 11(10): 1349-1355. http://www.ncbi.nlm.nih.gov/pubmed/23639606
    [20]
    PENG S, WAN Z, LIU T, et al. Cesarean section reduces the risk of early mother-to-child transmission of hepatitis B virus[J]. Dig Liver Dis, 2018, 50(10): 1076-1080. http://europepmc.org/abstract/MED/29853270
    [21]
    CHEN HL, CAI JY, SONG YP, et al. Vaginal delivery and HBV mother to child transmission risk after immunoprophylaxis: A systematic review and a meta-analysis[J]. Midwifery, 2019, 74: 116-125. http://www.sciencedirect.com/science/article/pii/S026661381930083X
    [22]
    SCHILLIE S, VELLOZZI C, REINGOLD A, et al. Prevention of hepatitis B virus infection in the United States: Recommendations of the advisory committee on immunization practices[J]. MMWR Recomm Rep, 2018, 67(1): 1-31. http://www.ncbi.nlm.nih.gov/pubmed/29939980
    [23]
    CHEN X, CHEN J, WEN J, et al. Breastfeeding is not a risk factor for mother-to-child transmission of hepatitis B virus[J]. PLoS One, 2013, 8(1): e55303. http://pubmedcentralcanada.ca/pmcc/articles/PMC3557270/?lang=fr
    [24]
    SHI Z, YANG Y, WANG H, et al. Breastfeeding of newborns by mothers carrying hepatitis B virus: A meta-analysis and systematic review[J]. Arch Pediatr Adolesc Med, 2011, 165(9): 837-846. http://labs.europepmc.org/abstract/MED/21536948
    [25]
    EHRHARDT S, XIE C, GUO N, et al. Breastfeeding while taking lamivudine or tenofovir disoproxil fumarate: A review of the evidence[J]. Clin Infect Dis, 2015, 60(2): 275-278. http://cid.oxfordjournals.org/content/60/2/275.full
    [26]
    YI W, PAN CQ, LI MH, et al. The characteristics and predictors of postpartum hepatitis flares in women with chronic hepatitis B[J]. Am J Gastroenterol, 2018, 113(5): 686-693. http://www.nature.com/articles/s41395-018-0010-2
    [27]
    Antiretroviral Pregnancy Registry Interim Report for 1 January 1989-31 January 2020[EB/OL].[2021-02-01]. http://www.apregistry.com/forms/exec-summary.pdf.
    [28]
    WEN WH, CHEN HL, SHIH TT, et al. Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT study). Long-term growth and bone development in children of HBV-infected mothers with and without fetal exposure to tenofovir disoproxil fumarate[J]. J Hepatol, 2020, 72(6): 1082-1087.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (1509) PDF downloads(813) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return